PALATINE, Ill., Feb. 14, 2011 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that ...
PALATINE, Ill., and BRISTOL, Tenn., Mar 3, 2009 -- Acura Pharmaceuticals and King Pharmaceuticals today announced that Acura's New Drug Application (NDA) for Acurox(r) (oxycodone HCl/niacin) Tablets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback